Literature DB >> 24029488

Encapsulation of simvastatin in PLGA microspheres loaded into hydrogel loaded BCP porous spongy scaffold as a controlled drug delivery system for bone tissue regeneration.

Subrata D Nath1, Nguyen T B Linh, Alexander Sadiasa, Byong T Lee.   

Abstract

The main objective of this study was to fabricate a controlled drug delivery which is simultaneously effective for bone regeneration. We have encapsulated simvastatin, which enhances osteoblastic activity, in the poly (lactic-co-glycolic acid) microspheres. Loading of these microspheres inside the spongy scaffold of biphasic calcium phosphate with the help of Gelatin (Gel) hydrogel controls the delivery of the drug, and ensures a more favorable drug release profile. As a result, some significant benefits have been achieved, such as higher mechanical strength, excellent biocompatibility in in vitro experiments. For determining the characteristics of the composite scaffold, several analysis, such as scanning electron microscope, EDX, X-ray diffraction, FT-IR, and porosity were carried out. The in vitro drug release profile clearly indicates that simvastatin release from the microsphere was more controlled and prolonged after loading in the scaffold. Biocompatibility was certainly higher for the final composite scaffold compared to drug unloaded scaffold, as assessed through MTT assay and Confocal imaging with MC3T3-E1 pre-osteoblast cells. Cell attachment and proliferation were certainly higher in the presence of drug loaded microspheres. Bone remodeling gene and protein expression were observed by real-time polymerase chain reaction and Western blot respectively. Simvastatin loaded scaffold exhibited the best results in every determination which was carried out.

Entities:  

Keywords:  BCP; PLGA; Sponge replica; drug delivery; scaffold; simvastatin

Mesh:

Substances:

Year:  2013        PMID: 24029488     DOI: 10.1177/0885328213499272

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  5 in total

1.  PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment.

Authors:  Tao Wu; Lei Tan; Ning Cheng; Qi Yan; Yu-Feng Zhang; Chuan-Jun Liu; Bin Shi
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-01-08       Impact factor: 7.328

2.  Pullulan microbeads/Si-HPMC hydrogel injectable system for the sustained delivery of GDF-5 and TGF-β1: new insight into intervertebral disc regenerative medicine.

Authors:  Nina Henry; Johann Clouet; Audrey Fragale; Louise Griveau; Claire Chédeville; Joëlle Véziers; Pierre Weiss; Jean Le Bideau; Jérôme Guicheux; Catherine Le Visage
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines.

Authors:  Konrad Wróbel; Stanisław Wołowiec; Joanna Markowicz; Elżbieta Wałajtys-Rode; Łukasz Uram
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

4.  Enhanced in vitro osteoblast differentiation on TiO2 scaffold coated with alginate hydrogel containing simvastatin.

Authors:  Helen Pullisaar; Hanna Tiainen; Maria A Landin; Ståle P Lyngstadaas; Håvard J Haugen; Janne E Reseland; Esben Ostrup
Journal:  J Tissue Eng       Date:  2013-11-26       Impact factor: 7.813

5.  Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.

Authors:  Bor-Shiunn Lee; Chien-Chen Lee; Yi-Ping Wang; Hsiao-Jan Chen; Chern-Hsiung Lai; Wan-Ling Hsieh; Yi-Wen Chen
Journal:  Int J Nanomedicine       Date:  2016-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.